Literature DB >> 19517230

Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients.

Dae Won Jun1, Kyung Tae Kim, Oh Young Lee, Jeong Don Chae, Byoung Kwan Son, Seong Hwan Kim, Yun Ju Jo, Young Sook Park.   

Abstract

BACKGROUND: Small intestinal bacterial overgrowth (SIBO) is regarded as the major risk factor of bacterial translocation. Few studies have investigated the direct relation between SIBO and translocation in cirrhotic patients. The purpose of this study is to examine the correlation between SIBO and bacterial DNA in the peripheral blood of patients with cirrhosis. AIMS: The purpose of this study is to examine the correlation between SIBO and bacterial DNA in the peripheral blood of patients with cirrhosis.
METHODS: Fifty-three cirrhosis cases and 42 controls underwent a lactulose breath test (LBT) every 15 min for 180 min. To detect and identify the presence of bacterial DNA fragments in peripheral blood, multiplex polymerase chain reaction (PCR) was performed.
RESULTS: The positive rate of LBT was significantly different between the two groups: 60.4% in the patient group and 28.6% in the controls. The SIBO positive rate was 81.3% in the cirrhosis patients with ascites, which was significantly higher than 51.4% in the cirrhosis patients with no ascites (P = 0.03). Eight of the nine patients (88.9%) who had a history of one or more hepatic encephalopathy was SIBO-positive, which was higher than the patients who had had no hepatic encephalopathy. In the cirrhosis group, 32 patients (60.4%) were SIBO-positive, and ten of them (31.3%) were bacterial DNA-positive. Only one case (4.8%) was bacterial DNA-positive in the absence of SIBO-positive. In a multivariate analysis, only the existence of SIBO was the independent risk factor for bacterial DNA (P = 0.026).
CONCLUSIONS: SIBO in cirrhosis patients was observed at a very high frequency, and SIBO showed a high correlation with bacterial translocation, suggesting that SIBO could be a major risk factor of bacterial translocation, especially in ascitic patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19517230     DOI: 10.1007/s10620-009-0870-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

1.  Does blood of healthy subjects contain bacterial ribosomal DNA?

Authors:  S Nikkari; I J McLaughlin; W Bi; D E Dodge; D A Relman
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Annealing control primer system for identification of differentially expressed genes on agarose gels.

Authors:  Yun-Jee Kim; Chae-Il Kwak; Young-Yun Gu; In-Taek Hwang; Jong-Yoon Chun
Journal:  Biotechniques       Date:  2004-03       Impact factor: 1.993

3.  Effect of comprehensive validation of the template isolation procedure on the reliability of bacteraemia detection by a 16S rRNA gene PCR.

Authors:  A Heininger; M Binder; A Ellinger; J Pfisterer; K Botzenhart; K Unertl; G Döering
Journal:  Clin Microbiol Infect       Date:  2004-05       Impact factor: 8.067

4.  Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia.

Authors:  Tilman M Bauer; Henning Schwacha; Bernhard Steinbrückner; Folke E Brinkmann; Anette K Ditzen; John J Aponte; Klaus Pelz; Dieter Berger; Manfred Kist; Hubert E Blum
Journal:  Am J Gastroenterol       Date:  2002-09       Impact factor: 10.864

Review 5.  Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics.

Authors:  Eamonn M M Quigley; Rodrigo Quera
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

6.  Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis.

Authors:  Rubén Francés; Pedro Zapater; José M González-Navajas; Carlos Muñoz; Rocío Caño; Rocío Moreu; Sonia Pascual; Pablo Bellot; Miguel Pérez-Mateo; José Such
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

7.  Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene.

Authors:  Jong-Yoon Chun; Kyoung-Joong Kim; In-Taek Hwang; Yun-Jee Kim; Dae-Hoon Lee; In-Kyoung Lee; Jong-Kee Kim
Journal:  Nucleic Acids Res       Date:  2007-02-07       Impact factor: 16.971

  7 in total
  36 in total

Review 1.  Bacterial infections in end-stage liver disease: current challenges and future directions.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; Florence Wong; K Rajender Reddy; Patrick S Kamath
Journal:  Gut       Date:  2012-06-03       Impact factor: 23.059

2.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

Review 3.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

4.  Publisher Correction: The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-12       Impact factor: 46.802

Review 5.  Markers of bacterial translocation in end-stage liver disease.

Authors:  Ioannis Koutsounas; Garyfallia Kaltsa; Spyros I Siakavellas; Giorgos Bamias
Journal:  World J Hepatol       Date:  2015-09-18

6.  Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis.

Authors:  Roman Maslennikov; Chavdar Pavlov; Vladimir Ivashkin
Journal:  Hepatol Int       Date:  2018-10-04       Impact factor: 6.047

7.  Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.

Authors:  J S Bajaj; S M Ratliff; D M Heuman; K L Lapane
Journal:  Aliment Pharmacol Ther       Date:  2012-11       Impact factor: 8.171

8.  Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice.

Authors:  Phillipp Hartmann; Peng Chen; Hui J Wang; Lirui Wang; Declan F McCole; Katharina Brandl; Peter Stärkel; Clara Belzer; Claus Hellerbrand; Hidekazu Tsukamoto; Samuel B Ho; Bernd Schnabl
Journal:  Hepatology       Date:  2013-05-27       Impact factor: 17.425

9.  A multicenter prospective study of infections related morbidity and mortality in cirrhosis of liver.

Authors:  Rajiv Baijal; Deepak Amarapurkar; H R Praveen Kumar; Sandeep Kulkarni; Nimish Shah; Soham Doshi; Deepak Gupta; Mayank Jain; Nikhil Patel; Praful Kamani; S K Issar; Mrudul Dharod; Apoorva Shah; Madhuri Chandnani; Sonali Gautam
Journal:  Indian J Gastroenterol       Date:  2014-06-01

10.  Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.

Authors:  Melissa Ratelle; Sylvie Perreault; Jean-Pierre Villeneuve; Lydjie Tremblay
Journal:  Can J Gastroenterol Hepatol       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.